1 SEC 13D/G filing tracked · Last updated Oct 19, 2026
$XBIT - XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cance…
